Two office buildings in Collegeville have sold to Audubon-based Globus Medical for $6.2 million, marking an 81 percent drop ...

On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $77.5, a high ...

Two mostly vacant office buildings in Montgomery County lost the majority of their value in a foreclosure sale.

AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share ...

Globus Medical stands out for its commitment to improving patient care through advanced technology, including regenerative biologic products. Founded in 2003 and based in Audubon, Pennsylvania ...

Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...

Globus Medical AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first ...

Pennsylvania-based Globus Medical, Inc. company is primarily focused on products for knee and hip procedures, as well as robotic and imaging systems. However, its main business is providing a wide ...

Globus Medical (NYSE:GMED) has observed the following analyst ratings within the last quarter: In the last 3 months, 6 analysts have offered 12-month price targets for Globus Medical. The company ...